ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,930,000 | – | 128,000 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,290,586 | $95,617,000 | 8.40% |
| Redmile Group, LLC | 15,906,680 | $241,782,000 | 7.44% |
| First Light Asset Management, LLC | 2,381,146 | $36,193,000 | 5.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 844,500 | $9,844,000 | 4.68% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 355,157 | $5,397,000 | 4.30% |
| SECTORAL ASSET MANAGEMENT INC | 2,094,167 | $31,831,000 | 3.38% |
| X-Square Capital, LLC | 183,862 | $2,795,000 | 1.85% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 334,604 | $5,086,000 | 1.67% |
| Birchview Capital, LP | 128,000 | $1,946,000 | 1.26% |
| Rhenman & Partners Asset Management AB | 768,370 | $11,679,000 | 1.17% |